Facebook
X
LinkedIn
Forward
0599_ABSMC_Mutliple Sclerosis Conference_Live
Description:
Multiple Sclerosis (MS) is a chronic neurological condition in which the immune system erroneously targets the myelin sheath, the protective layer surrounding nerve fibers in the brain and spinal cord. Affecting approximately 1 in 300 individuals in the United States, MS presents a range of complex clinical challenges. This conference will provide healthcare professionals with the latest evidence-based updates in diagnosing, managing, and treating MS. Key topics will include advancements in imaging techniques, considerations across the reproductive lifespan (including pregnancy, lactation, and menopause), and comprehensive strategies for rehabilitation and symptom management. Attendees will gain practical insights to enhance care for patients living with MS.
Target Audience
Pharmacists (PharmD)
Physicians (MD or DO)
Nurse Practitioner (NP)
Nurse, Registered (RN)
Physician Assistant (PA)
Other Healthcare Professionals
Learning Objectives
Upon completion of this learning activity, participants should be able to:
• Describe how pregnancy planning impacts the treatment of MS
• Discuss the management of immunotherapy during pregnancy and the post-partum period
• Learn how breastfeeding is impacted in patients on the treatment of MS
• Appraise the utility of newer techniques, including central vein sign and paramagnetic rim lesions in distinguishing MS from other conditions
• Examine the role of advanced neuroimaging techniques in measuring silent progression in MS
• Consider other medical conditions that may present similarly or resemble Multiple Sclerosis on neuroimaging
• Compare commonly used immunotherapies for other neuroimmunologic conditions and how treatment may differ from MS therapies
• Summarize the range of multiple sclerosis symptoms • Explain why treatment for symptoms is important
• Appraise the appropriate approach to symptom management
• Recall key symptoms and treatment
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
Dr. Riley Bove
Title: Women’s Issues and MS Care
Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis. Neurology, 104(2), e210228. https://doi.org/10.1212/WNL.0000000000210228
Social Determinants of Health and Bias reference:
- Radzik, A.M., Amezcua, L., Anderson, A., Gilmore, S., Ahmad, S., Brandstadter, R., Fabian, M.T., Graham, E.L., Hodgkinson, S., Horton, L., Jacobs, D.A., Katz Sand, I.B., Kohli, A., Levine, L., McLemore, M., Okai, A.F., Patel, J., Poole, S., Riley, C., Tardo, L., Verter, E., Villacorta, V., Zimmerman, V., Zuroff, L., Williams, M.J., Houtchens, M.K....Bove, R. (2024, February 27). Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort. Neurology, 102(4), e208100. https://doi.org/10.1212/WNL.0000000000208100
- Rosendale, N., Ostendorf, T., Evans, D., Weathers, A., Sico, J., Randall, J., Hinson, H., Evans, D.A., Sico, J.J., & Hinson, H.E. (2019, July 23). American Academy of Neurology members' preparedness to treat sexual and gender minorities. Neurology, 93(4), 159-166. https://doi.org/10.1212/WNL.0000000000007829
Dr. Roland Henry
Title: Conventional and Advancing Imaging in MS
Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model F, Koendgen H, Manfrini M, Belachew S, Hauser SL.JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568.PMID: 32511687
Social Determinates of Health
Mersha, T.B., Abebe, T. Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum Genomics 9, 1 (2015). https://doi.org/10.1186/s40246-014-0023-x
Dr. Jeffrey M Gelfand
Title: Differential Diagnosis MS Mimics and Related Disorders
Social Determinants of Health & Implicit Bias
Amezcua, L., & McCauley, J. L. (2020). Race and ethnicity on MS presentation and disease course. Multiple sclerosis (Houndmills, Basingstoke, England), 26(5), 561–567. https://doi.org/10.1177/1352458519887328
Dr. Joanna Cooper
Title: Multiple Sclerosis Symptoms & Treatment Interventions
Social Determinants of Health & Implicit Bias
Amezcua, L., Rivera, V. M., Vazquez, T. C., Baezconde-Garbanati, L., & Langer-Gould, A. (2021). Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review. JAMA neurology, 78(12), 1515–1524. https://doi.org/10.1001/jamaneurol.2021.3416
Cindy T Nguyen, PharmD
Title: Roles of Advanced Clinician & Advanced Practice Pharmacist in Management of MS
Social Determinants of Health
Williams, M. J., Amezcua, L., Cohan, S. L., Cohen, J. A., Delgado, S. R., Hua, L. H., Lucassen, E. B., Piccolo, R. S., Koulouris, C. R., & Stankiewicz, J. (2024). Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses. Neurology, 103(3), e209610. https://doi.org/10.1212/WNL.0000000000209610
Implicit bias :
Hall, W. J., Chapman, M. V., Lee, K. M., Merino, Y. M., Thomas, T. W., Payne, B. K., Eng, E., Day, S. H., & Coyne-Beasley, T. (2015). Implicit Racial/Ethnic Bias Among Health Care Professionals and Its Influence on Health Care Outcomes: A Systematic Review. American journal of public health, 105(12), e60–e76. https://doi.org/10.2105/AJPH.2015.302903
Dr. Alisson Capizzi
Title: Rehabilitation Principles for Patients with Multiple Sclerosis
Time:45 Minutes
Social Determinants of Health and Bias reference:
Amezcua L, Rivera VM, Vazquez TC, Baezconde-Garbanati L, Langer-Gould A. Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review. JAMA Neurol. 2021 Dec 1;78(12):1515-1524. doi: 10.1001/jamaneurol.2021.3416. PMID: 34605866.
Robers MV, Amezcua L. Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health. Curr Opin Neurol. 2024 Jun 1;37(3):245-251. doi: 10.1097/WCO.0000000000001264. Epub 2024 Mar 20. PMID: 38506756.
Dr. Deepak Soneji
Title: Overview of Multiple Sclerosis
Social Determinants of Health:
Amezcua, L., Rivera, V.M., Vazquez, T.C., Baezconde-Garbanati, L., & Langer-Gould, A. (2021, December Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review. JAMA neurology, 78(12), 1515-1524. https://doi.org/10.1001/jamaneurol.2021.3416
Implicit Bias
Mateen, F. J., et al. (2023). Perceptions of people with multiple sclerosis on social determinants of health: Mixed methods. Multiple Sclerosis and Related Disorders, 80, 105089.
SDoH/CLC/Implicit Bias:
Buetow, S. (2024). Ageism and Person-Centred Care: Rehabilitating Bias for Age-Friendly Practice. Taylor & Francis.
Ogrin, R., Meyer, C., Appannah, A., McMillan, S., & Browning, C. (2020). The inter-relationship of diversity principles for the enhanced participation of older people in their care: a qualitative study. International journal for equity in health, 19, 1-13.
Morgan, E., De Lima, B., Pleet, A., & Eckstrom, E. (2022). Health equity in an age-friendly health system: identifying potential care gaps. The Journals of Gerontology: Series A, 77(11), 2306-2310.
Wolfe, M., & Gracia, J. N. (2023). The value of age-friendly public health systems in the age-friendly ecosystem. Geriatrics, 8(3), 63.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
Roland Henry, faculty for this presentation, receives speaker/consultant fees from Novartis, Roche and Sanofi. These relevant ineligible relationships were mitigated via peer review by Dr. Deepak Soneji who does not have any ineligible financial relationships.
Jeffrey Gelfand, faculty for this presentation, receives speaker/consultant fees from Arialys and VentyxBio. He also received a grant from Hoffman LaRoche and Vigil Neuroscience. These relevant ineligible relationships were mitigated via peer review by Dr. Deepak Soneji who does not have any ineligible financial relationships.
Riley Bove, faculty for this presentation, receives speaker/consultant fees from Amgen, Alexion, EMB Seremo, TG Therapeutics, Cadenza and Genzyme. He also received a grant from Biogen, Eli Lily, Novartis, Roche Genetech. These relevant ineligible relationships were mitigated via peer review by Dr. Deepak Soneji who does not have any ineligible financial relationships.
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Fozia Ferozali, Ed.D
Joanna Cooper, MD
Deepak Soneji, MD, PhD
Riley Bove, MD
Allison Capizzi, MD
Joanna Cooper, MD
Jeffrey Gelfand, Associate Professor of Neurology, UCSF
Roland Henry, PhD
Lynn Jehle, RN, MS, CPNP
Cindy Nguyen, PharmD, MPH, MS, BCPS, APh
Deepak Soneji, MD, PhD
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 4.50 AMA PRA Category 1 Credits™ for physicians, 4.50 continuing professional development contact hours for nurses, 4.50 knowledge-based contact hours for pharmacists, . Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Available Credit
- 4.50 ACPE
Pharmacy Credit - Accreditation Council of Pharmacy Education (ACPE)
Sutter Health designates this Live activity for a maximum of 4.50 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.
- 4.50 AMA PRA Category 1 Credit™
Physician Credit
Sutter Health designates this Live activity for a maximum of 4.50 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.50 Non-Physician Participation Credit
Sutter Health designates this Live activity for a maximum of 4.50 Non-Physician Participation Credit. Non-Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
- 4.50 ANCC
Nursing Credit - American Nurses Credentialing Center (ANCC)
Sutter Health designates this Live activity for a maximum of 4.50 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
- 4.50 CA BRN
Nursing Credit - California Board of Registered Nursing (CA BRN)
This activity is approved for 4.50 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Nurses should claim only the credit commensurate with the extent of their participation in the activity. - 4.50 IPCE
This activity was planned by and for the healthcare team, and learners will receive 4.50 Interprofessional Continuing Education (IPCE) credit for learning and change.